{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:43:13Z","timestamp":1790005393348,"version":"4.0.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Seppo Nieminen Fund","award":["150636"],"award-info":[{"award-number":["150636"]}]},{"name":"Seppo Nieminen Fund","award":["150620"],"award-info":[{"award-number":["150620"]}]},{"name":"Ida Montin Fund","award":["20180260"],"award-info":[{"award-number":["20180260"]}]},{"name":"the Finnish Society for Oncology","award":["-"],"award-info":[{"award-number":["-"]}]},{"name":"the competitive state financing of the expert responsibility area of the Tampere University Hospital","award":["-"],"award-info":[{"award-number":["-"]}]},{"DOI":"10.13039\/501100007417","name":"Paulo Foundation","doi-asserted-by":"crossref","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13014-019-1366-1","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T20:01:44Z","timestamp":1567195304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Transforming growth factor beta 1 levels predict echocardiographic changes at three years after adjuvant radiotherapy for breast cancer"],"prefix":"10.1186","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-517X","authenticated-orcid":false,"given":"Hanna","family":"Aula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Skytt\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvi","family":"Tuohinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiina","family":"Luukkaala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"H\u00e4m\u00e4l\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pekka","family":"Raatikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eeva","family":"Moilanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirkko-Liisa","family":"Kellokumpu-Lehtinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"1366_CR1","doi-asserted-by":"publisher","unstructured":"Cheng Y, Nie X, Ji C, Lin X, Liu L, Chen X, et al. Long-term cardiovascular risk after radiotherapy in women with breast Cancer. J Am Heart Assoc. 2017;6. \n                    https:\/\/doi.org\/10.1161\/JAHA.117.005633\n                    \n                  .","DOI":"10.1161\/JAHA.117.005633"},{"key":"1366_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.radonc.2010.09.002","volume":"97","author":"J Yarnold","year":"2010","unstructured":"Yarnold J, Vozenin Brotons M-C. Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol. 2010;97:149\u201361. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2010.09.002\n                    \n                  .","journal-title":"Radiother Oncol"},{"key":"1366_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"Nikolaos G. Frangogiannis","year":"2019","unstructured":"Frangogiannis NG. Cardiac fibrosis: cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Asp Med. 2018. \n                    https:\/\/doi.org\/10.1016\/j.mam.2018.07.001\n                    \n                  .","journal-title":"Molecular Aspects of Medicine"},{"key":"1366_CR4","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","volume":"342","author":"GC Blobe","year":"2000","unstructured":"Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor \u03b2 in human disease. N Engl J Med. 2000;342:1350\u20138. \n                    https:\/\/doi.org\/10.1056\/NEJM200005043421807\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1366_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/hmg\/8.1.93","volume":"8","author":"DJ Grainger","year":"1999","unstructured":"Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet. 1999;8:93\u20137.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"1366_CR6","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1001\/jamaoncol.2018.2583","volume":"4","author":"Aaron J. Grossberg","year":"2018","unstructured":"Grossberg AJ, Lei X, Xu T, Shaitelman SF, Hoffman KE, Bloom ES, et al. Association of Transforming Growth Factor \u03b2 polymorphism C\u2212509T with radiation-induced fibrosis among patients with early-stage breast Cancer. JAMA Oncol. 2018. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2018.2583\n                    \n                  .","journal-title":"JAMA Oncology"},{"key":"1366_CR7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.radonc.2011.10.017","volume":"102","author":"FSM Hilbers","year":"2012","unstructured":"Hilbers FSM, Boekel NB, van den Broek AJ, van Hien R, Cornelissen S, Aleman BMP, et al. Genetic variants in TGF\u03b2-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. Radiother Oncol. 2012;102:115\u201321. \n                    https:\/\/doi.org\/10.1016\/j.radonc.2011.10.017\n                    \n                  .","journal-title":"Radiother Oncol"},{"key":"1366_CR8","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<155::AID-IJC11>3.0.CO;2-S","volume":"84","author":"C Li","year":"1999","unstructured":"Li C, Wilson PB, Levine E, Barber J, Stewart AL, Kumar S. TGF-beta1 levels in pre-treatment plasma identify breast cancer patients at risk of developing post-radiotherapy fibrosis. Int J Cancer. 1999;84:155\u20139.","journal-title":"Int J Cancer"},{"key":"1366_CR9","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.ijrobp.2013.08.045","volume":"87","author":"DL Boothe","year":"2013","unstructured":"Boothe DL, Coplowitz S, Greenwood E, Barney CL, Christos PJ, Parashar B, et al. Transforming growth factor \u03b2-1 (TGF-\u03b21) is a serum biomarker of radiation induced fibrosis in patients treated with Intracavitary accelerated partial breast irradiation: preliminary results of a prospective study. Int J Radiat Oncol Biol Phys. 2013;87:1030\u20136. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2013.08.045\n                    \n                  .","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1366_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s13014-018-1150-7.","volume":"13","author":"H Aula","year":"2018","unstructured":"Aula H, Skytt\u00e4 T, Tuohinen S, Luukkaala T, H\u00e4m\u00e4l\u00e4inen M, Virtanen V, et al. Decreases in TGF-\u03b21 and PDGF levels are associated with echocardiographic changes during adjuvant radiotherapy for breast cancer. Radiat Oncol. 2018;13:201. \n                    https:\/\/doi.org\/10.1186\/s13014-018-1150-7.","journal-title":"Radiat Oncol"},{"key":"1366_CR11","first-page":"2141","volume":"35","author":"SS Tuohinen","year":"2015","unstructured":"Tuohinen SS, Skytta T, Virtanen V, Luukkaala T, Kellokumpu-Lehtinen P-L, Raatikainen P. Early effects of adjuvant breast cancer radiotherapy on right ventricular systolic and diastolic function. Anticancer Res. 2015;35:2141\u20137.","journal-title":"Anticancer Res"},{"key":"1366_CR12","first-page":"1559","volume":"35","author":"T Skytta","year":"2015","unstructured":"Skytta T, Tuohinen S, Virtanen V, Raatikainen P, Kellokumpu-Lehtinen P-L. The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer. Anticancer Res. 2015;35:1559\u201366.","journal-title":"Anticancer Res"},{"key":"1366_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s10554-016-1021-y","volume":"33","author":"SS Tuohinen","year":"2017","unstructured":"Tuohinen SS, Skytta T, Poutanen T, Huhtala H, Virtanen V, Kellokumpu-Lehtinen P-L, et al. Radiotherapy-induced global and regional differences in early-stage left-sided versus right-sided breast cancer patients: speckle tracking echocardiography study. Int J Cardiovasc Imaging. 2017;33:463\u201372. \n                    https:\/\/doi.org\/10.1007\/s10554-016-1021-y\n                    \n                  .","journal-title":"Int J Cardiovasc Imaging"},{"key":"1366_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s10554-016-0837-9","volume":"32","author":"SS Tuohinen","year":"2016","unstructured":"Tuohinen SS, Skytta T, Virtanen V, Virtanen M, Luukkaala T, Kellokumpu-Lehtinen P-L, et al. Detection of radiotherapy-induced myocardial changes by ultrasound tissue characterisation in patients with breast cancer. Int J Cardiovasc Imaging. 2016;32:767\u201376. \n                    https:\/\/doi.org\/10.1007\/s10554-016-0837-9\n                    \n                  .","journal-title":"Int J Cardiovasc Imaging"},{"key":"1366_CR15","doi-asserted-by":"publisher","DOI":"10.4159\/9780674041318","volume-title":"Group-based modeling of development","author":"DS Nagin","year":"2005","unstructured":"Nagin DS. Group-based modeling of development. Cambridge: Harvard Univesity Press; 2005. \n                    https:\/\/doi.org\/10.4159\/9780674041318\n                    \n                  ."},{"key":"1366_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research. Annu Rev Clin Psychol. 2010;6:109\u201338. \n                    https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131413\n                    \n                  .","journal-title":"Annu Rev Clin Psychol"},{"key":"1366_CR17","volume-title":"FlexMix: A general framework for finite mixture models and latent glass regression in R","author":"F Leisch","year":"2004","unstructured":"Leisch F. FlexMix: A general framework for finite mixture models and latent glass regression in R, vol. 11; 2004."},{"key":"1366_CR18","volume-title":"R: a language and environment for statistical computing","author":"R core team","year":"2018","unstructured":"R core team. R: a language and environment for statistical computing 2018."},{"key":"1366_CR19","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.ijrobp.2007.05.034","volume":"69","author":"CW Taylor","year":"2007","unstructured":"Taylor CW, Nisbet A, McGale P, Darby SC. Cardiac exposures in breast Cancer radiotherapy: 1950s\u20131990s. Int J Radiat Oncol. 2007;69:1484\u201395. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2007.05.034\n                    \n                  .","journal-title":"Int J Radiat Oncol"},{"key":"1366_CR20","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1016\/j.ijrobp.2009.04.093","volume":"76","author":"G Gagliardi","year":"2010","unstructured":"Gagliardi G, Constine LS, Moiseenko V, Correa C, Pierce LJ, Allen AM, et al. Radiation dose\u2013volume effects in the heart. Int J Radiat Oncol. 2010;76:S77\u201385. \n                    https:\/\/doi.org\/10.1016\/j.ijrobp.2009.04.093\n                    \n                  .","journal-title":"Int J Radiat Oncol"},{"key":"1366_CR21","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1136\/heartjnl-2014-305538","volume":"100","author":"K Kalam","year":"2014","unstructured":"Kalam K, Otahal P, Marwick TH. Prognostic implications of global LV dysfunction: a systematic review and meta-analysis of global longitudinal strain and ejection fraction. Heart. 2014;100:1673\u201380. doi. \n                    https:\/\/doi.org\/10.1136\/heartjnl-2014-305538\n                    \n                  .","journal-title":"Heart"},{"key":"1366_CR22","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Colvin MM, et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart failure Society of Amer. Circulation. 2017;136:e137\u201361. \n                    https:\/\/doi.org\/10.1161\/CIR.0000000000000509\n                    \n                  .","journal-title":"Circulation"},{"key":"1366_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","volume":"1782","author":"KJ Gordon","year":"2008","unstructured":"Gordon KJ, Blobe GC. Role of transforming growth factor-\u03b2 superfamily signaling pathways in human disease. Biochim Biophys Acta - Mol Basis Dis. 2008;1782:197\u2013228. \n                    https:\/\/doi.org\/10.1016\/j.bbadis.2008.01.006\n                    \n                  .","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"1366_CR24","doi-asserted-by":"publisher","first-page":"e0162221","DOI":"10.1371\/journal.pone.0162221","volume":"11","author":"SD Scherer","year":"2016","unstructured":"Scherer SD, Bauer J, Schmaus A, Neumaier C, Herskind C, Veldwijk MR, et al. TGF-\u03b21 is present at high levels in wound fluid from breast Cancer patients immediately post-surgery, and is not increased by intraoperative radiation therapy (IORT). PLoS One. 2016;11:e0162221. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0162221\n                    \n                  .","journal-title":"PLoS One"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1366-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13014-019-1366-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-019-1366-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:10:54Z","timestamp":1598656254000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-019-1366-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1366"],"URL":"https:\/\/doi.org\/10.1186\/s13014-019-1366-1","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"14 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Tampere University hospital ethics committee approved the study (R10160) and informed consent was obtained from all participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}